HHS awarded Rite Aid $214M for medical lab services, a sole-source contract during a critical period

Contract Overview

Contract Amount: $213,950,016 ($214.0M)

Contractor: Rite AID Hdqtrs. Corp.

Awarding Agency: Department of Health and Human Services

Start Date: 2021-10-01

End Date: 2022-05-31

Contract Duration: 242 days

Daily Burn Rate: $884.1K/day

Competition Type: NOT COMPETED

Number of Offers Received: 1

Pricing Type: FIXED PRICE INCENTIVE

Sector: Healthcare

Official Description: INCREASE COMMUNITY ACCESS TO TESTING (ICATT)

Place of Performance

Location: CAMP HILL, CUMBERLAND County, PENNSYLVANIA, 17011

State: Pennsylvania Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $214.0 million to RITE AID HDQTRS. CORP. for work described as: INCREASE COMMUNITY ACCESS TO TESTING (ICATT) Key points: 1. The contract's value of $214M represents a significant investment in medical laboratory services. 2. Sole-source procurement raises questions about potential price inflation and limited market engagement. 3. The short duration (242 days) suggests an urgent need or a bridge to a future solution. 4. Performance context is limited due to the lack of competitive bidding. 5. The contract falls within the broader healthcare sector, specifically medical laboratories. 6. The absence of small business set-asides indicates a focus on larger prime contractors.

Value Assessment

Rating: questionable

Benchmarking the value of this contract is challenging due to its sole-source nature and the specific context of its award. Without competitive bids, it's difficult to assess if the $214M represents a fair market price for the medical laboratory services provided. The fixed-price incentive structure suggests an attempt to control costs, but the lack of comparison data makes a definitive value assessment difficult. The contract's duration also plays a role; a shorter term might justify a higher per-unit cost if it addresses an immediate, critical need.

Cost Per Unit: N/A

Competition Analysis

Competition Level: sole-source

This contract was awarded on a sole-source basis, meaning only one vendor, Rite Aid HDQTRS. CORP., was solicited. This approach bypasses the standard competitive bidding process, which typically involves multiple vendors submitting proposals. While sole-source awards can be justified in specific circumstances, such as urgent needs or when only one vendor possesses the required capabilities, they limit price discovery and potentially reduce the government's ability to secure the best value.

Taxpayer Impact: Sole-source awards can lead to higher costs for taxpayers as competition is absent, potentially allowing the awarded contractor to charge a premium. It also limits opportunities for other businesses to compete for government contracts.

Public Impact

The primary beneficiaries are likely the patients who received access to medical laboratory testing services. The contract facilitated the delivery of essential medical laboratory services across Pennsylvania. The geographic impact is concentrated in Pennsylvania, where Rite Aid has a significant retail presence. Workforce implications would primarily involve laboratory technicians and support staff employed by Rite Aid.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Lack of competition may have resulted in a higher price than a competitively bid contract.
Sole-source awards can set a precedent for future non-competitive procurements.
Limited transparency into the justification for sole-source award.
The fixed-price incentive structure's effectiveness is hard to gauge without performance data.
Short contract duration might indicate a reactive rather than strategic procurement.

Positive Signals

Contract awarded to a known entity (Rite Aid) with existing infrastructure.
The contract aimed to increase community access to testing, a critical public health objective.
Fixed-price incentive contract type can align contractor and government interests.
The contract was awarded by the Office of Assistant Secretary for Preparedness and Response, indicating a focus on emergency preparedness.

Sector Analysis

The medical laboratories sector (NAICS 621511) is a critical component of the healthcare industry, providing essential diagnostic services. The total government spending in this sector can fluctuate based on public health needs, such as pandemics. This contract with Rite Aid, a major pharmacy chain, highlights the trend of leveraging existing retail infrastructure for public health services. Comparable spending benchmarks would typically involve analyzing other large-scale contracts for laboratory services, particularly those awarded during public health emergencies.

Small Business Impact

This contract did not include a small business set-aside, as indicated by 'sb': false. The prime contractor, Rite Aid, is a large corporation. There is no explicit information provided regarding subcontracting plans or goals for small businesses. This suggests that the primary focus was on securing services from a large, established provider, potentially overlooking opportunities to engage smaller, specialized laboratory service providers.

Oversight & Accountability

Oversight mechanisms for this contract would typically involve the contracting officer's representative (COR) from the Department of Health and Human Services (HHS) and potentially the HHS Office of Inspector General (OIG). Given the sole-source nature and the fixed-price incentive structure, oversight would focus on ensuring that the services delivered meet the contract's requirements and that incentive targets are appropriately managed. Transparency is limited by the lack of a competitive bidding process, but contract award details are generally publicly available.

Related Government Programs

COVID-19 Testing Programs
Public Health Infrastructure Grants
Emergency Preparedness and Response Contracts
Healthcare Services Procurement
Diagnostic Laboratory Services

Risk Flags

Sole-source award bypasses competition.
Potential for inflated pricing due to lack of competition.
Limited transparency regarding justification for sole-source.
Short contract duration may indicate urgency or a stop-gap measure.

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $214.0 million to RITE AID HDQTRS. CORP.. INCREASE COMMUNITY ACCESS TO TESTING (ICATT)

Who is the contractor on this award?

The obligated recipient is RITE AID HDQTRS. CORP..

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (Office of Assistant Secretary for Preparedness and Response).

What is the total obligated amount?

The obligated amount is $214.0 million.

What is the period of performance?

Start: 2021-10-01. End: 2022-05-31.

What was the specific justification for awarding this contract on a sole-source basis?

The provided data does not explicitly state the justification for the sole-source award. However, given the contract's start date (October 2021) and end date (May 2022), it falls within the period of significant public health response to the COVID-19 pandemic. Sole-source awards are often justified under urgent and compelling circumstances, such as the need for immediate testing capacity or when only one entity possesses the unique capability to meet the requirement within the necessary timeframe. The 'INCREASE COMMUNITY ACCESS TO TESTING (ICATT)' program name also suggests a public health imperative that may have driven the decision to bypass full and open competition.

How does the contract's value compare to similar medical laboratory service contracts awarded by the government?

Direct comparison is difficult without knowing the specific services rendered and the geographic scope of other contracts. However, $214 million is a substantial amount for a contract with a duration of approximately 8 months. If this contract was for widespread community testing, the per-unit cost of tests would be a key metric. Without competitive data, it's hard to determine if this represents good value. Contracts awarded during the height of the pandemic for testing services varied widely in price depending on scale, location, and the specific testing technology employed. The sole-source nature prevents a direct benchmark against competitive bids.

What are the potential risks associated with a sole-source award of this magnitude?

The primary risk of a sole-source award is the potential for overpayment due to the lack of competitive pressure. Without competing bids, the government may not achieve the lowest possible price for the services. Additionally, sole-source awards can limit innovation by not engaging a broader market of potential providers. There's also a risk that the chosen contractor may not have the most efficient or effective solution compared to what could have been sourced through competition. Transparency is reduced, making it harder for the public and oversight bodies to scrutinize the procurement decision.

What does the 'FIXED PRICE INCENTIVE' (PT) contract type imply for performance and cost control?

A Fixed Price Incentive (FPI) contract type aims to share the risks and benefits of performance between the government and the contractor. It establishes an initial target cost, target profit, and a price ceiling. If the final costs are lower than the target, both parties share in the savings based on a pre-negotiated formula. Conversely, if costs exceed the target, the contractor assumes a larger portion of the overrun up to the price ceiling. This structure incentivizes the contractor to control costs while meeting performance objectives. However, the effectiveness of the incentive depends heavily on the accuracy of the initial cost targets and the clarity of performance metrics.

How has HHS spending on medical laboratories evolved over recent years, and does this contract represent a significant shift?

HHS spending on medical laboratories, particularly in the context of public health emergencies like COVID-19, has seen significant increases. This $214 million contract awarded to Rite Aid is substantial, especially considering its relatively short duration. It reflects a strategic decision to leverage existing retail pharmacy infrastructure for diagnostic services during a critical period. While specific historical spending data for HHS medical laboratories would be needed for a precise comparison, it's highly probable that spending in this category surged during the pandemic years. This contract is likely an example of that surge, driven by immediate public health needs rather than a long-term, steady-state expansion of laboratory services.

Industry Classification

NAICS: Health Care and Social Assistance › Medical and Diagnostic Laboratories › Medical Laboratories

Product/Service Code: MEDICAL SERVICES › LABORATORY TESTING SERVICES

Competition & Pricing

Extent Competed: NOT COMPETED

Solicitation Procedures: ONLY ONE SOURCE

Offers Received: 1

Pricing Type: FIXED PRICE INCENTIVE (L)

Evaluated Preference: NONE

Contractor Details

Parent Company: Rite AID Corporation

Address: 30 HUNTER LN, CAMP HILL, PA, 17011

Business Categories: Category Business, Corporate Entity Not Tax Exempt, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $213,950,016

Exercised Options: $213,950,016

Current Obligation: $213,950,016

Actual Outlays: $213,950,016

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED

Cost or Pricing Data: YES

Timeline